HomeCompareNTSE vs JNJ

NTSE vs JNJ: Dividend Comparison 2026

NTSE yields 3.14% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NTSE wins by $4.4K in total portfolio value
10 years
NTSE
NTSE
● Live price
3.14%
Share price
$39.75
Annual div
$1.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$384.21
Full NTSE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NTSE vs JNJ

📍 NTSE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNTSEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NTSE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NTSE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NTSE
Annual income on $10K today (after 15% tax)
$266.81/yr
After 10yr DRIP, annual income (after tax)
$326.58/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $377.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NTSE + JNJ for your $10,000?

NTSE: 50%JNJ: 50%
100% JNJ50/50100% NTSE
Portfolio after 10yr
$22.2K
Annual income
$606.00/yr
Blended yield
2.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NTSE
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NTSE buys
0
JNJ buys
0
No recent congressional trades found for NTSE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNTSEJNJ
Forward yield3.14%3.36%
Annual dividend / share$1.25$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$24.5K$20.0K
Annual income after 10y$384.21$827.78
Total dividends collected$3.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NTSE vs JNJ ($10,000, DRIP)

YearNTSE PortfolioNTSE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,014$313.89$10,676$355.77+$338.00NTSE
2$12,108$323.10$11,407$389.39+$701.00NTSE
3$13,287$331.96$12,198$426.53+$1.1KNTSE
4$14,558$340.46$13,056$467.62+$1.5KNTSE
5$15,926$348.62$13,987$513.12+$1.9KNTSE
6$17,397$356.42$14,998$563.56+$2.4KNTSE
7$18,979$363.87$16,098$619.52+$2.9KNTSE
8$20,678$370.99$17,295$681.69+$3.4KNTSE
9$22,503$377.76$18,599$750.82+$3.9KNTSE
10$24,463$384.21$20,022$827.78+$4.4KNTSE

NTSE vs JNJ: Complete Analysis 2026

NTSEStock

The fund seeks to achieve its investment objective by investing in emerging markets equity securities and U.S. Treasury futures contracts. It invests in a representative basket of emerging markets equity securities generally weighted by market capitalization. Under normal circumstances, the fund will invest approximately 90% of its net assets in the above-referenced equity securities. It is non-diversified.

Full NTSE Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NTSE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NTSE vs SCHDNTSE vs JEPINTSE vs ONTSE vs KONTSE vs MAINNTSE vs ABBVNTSE vs MRKNTSE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.